Vast Therapeutics
A Professor of Chemistry at the University of North Carolina at Chapel Hill where he has developed a dynamic research program in the field of nitric oxide. With nearly 20 years of experience as a chemist, he has published >100 peer-reviewed articles on nitric oxide-related technologies. He has a long-standing interest in developing macromolecular scaffolds that store and release nitric oxide for drug delivery and disease management applications.
This person is not in any offices
Vast Therapeutics
Vast is a preclinical biotechnology company focused on treating the world’s most challenging drug-resistant microbial infections that represent one of the greatest threats to global health, food security, and economic development.